Logo image of UBI.PA

UBISOFT ENTERTAINMENT (UBI.PA) Stock Fundamental Analysis

EPA:UBI - Euronext Paris - Matif - FR0000054470 - Common Stock - Currency: EUR

9.37  -0.08 (-0.89%)

Fundamental Rating

4

UBI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 49 industry peers in the Entertainment industry. UBI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. UBI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year UBI has reported negative net income.
UBI had a positive operating cash flow in the past year.
In multiple years UBI reported negative net income over the last 5 years.
Each year in the past 5 years UBI had a positive operating cash flow.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.18%, UBI is in line with its industry, outperforming 51.02% of the companies in the same industry.
The Return On Equity of UBI (-3.22%) is comparable to the rest of the industry.
UBI has a Return On Invested Capital (0.81%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.18%
ROE -3.22%
ROIC 0.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

With a Operating Margin value of 2.46%, UBI perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Looking at the Gross Margin, with a value of 90.35%, UBI is in the better half of the industry, outperforming 79.59% of the companies in the same industry.
In the last couple of years the Gross Margin of UBI has remained more or less at the same level.
Industry RankSector Rank
OM 2.46%
PM (TTM) N/A
GM 90.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UBI is destroying value.
There is no outstanding debt for UBI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

UBI has an Altman-Z score of 1.29. This is a bad value and indicates that UBI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of UBI (1.29) is comparable to the rest of the industry.
The Debt to FCF ratio of UBI is 4.55, which is a neutral value as it means it would take UBI, 4.55 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.55, UBI is in the better half of the industry, outperforming 61.22% of the companies in the same industry.
UBI has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
UBI's Debt to Equity ratio of 1.32 is on the low side compared to the rest of the industry. UBI is outperformed by 65.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 4.55
Altman-Z 1.29
ROIC/WACC0.15
WACC5.57%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.32 indicates that UBI has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.32, UBI belongs to the best of the industry, outperforming 87.76% of the companies in the same industry.
A Quick Ratio of 2.29 indicates that UBI has no problem at all paying its short term obligations.
The Quick ratio of UBI (2.29) is better than 87.76% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 2.29
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

UBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.28%.
Looking at the last year, UBI shows a very negative growth in Revenue. The Revenue has decreased by -17.46% in the last year.
UBI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.56% yearly.
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%

3.2 Future

Based on estimates for the next years, UBI will show a very strong growth in Earnings Per Share. The EPS will grow by 34.56% on average per year.
UBI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.18% yearly.
EPS Next Y253.57%
EPS Next 2Y102.74%
EPS Next 3Y64.12%
EPS Next 5Y34.56%
Revenue Next Year10.63%
Revenue Next 2Y7.23%
Revenue Next 3Y5.57%
Revenue Next 5Y5.18%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

UBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 10.90 indicates a reasonable valuation of UBI.
85.71% of the companies in the same industry are more expensive than UBI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of UBI to the average of the S&P500 Index (21.76), we can say UBI is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 10.9
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UBI is valued cheaper than 87.76% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UBI is valued cheaper than 89.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.4
EV/EBITDA 2.84
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

UBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UBI's earnings are expected to grow with 64.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y102.74%
EPS Next 3Y64.12%

0

5. Dividend

5.1 Amount

UBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UBISOFT ENTERTAINMENT

EPA:UBI (7/11/2025, 7:00:00 PM)

9.37

-0.08 (-0.89%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)10-28 2025-10-28
Inst Owners36.11%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.23B
Analysts55.24
Price Target13.1 (39.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20.63%
PT rev (3m)-21.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.9
P/S 0.58
P/FCF 2.4
P/OCF 1.96
P/B 0.73
P/tB N/A
EV/EBITDA 2.84
EPS(TTM)-0.56
EYN/A
EPS(NY)0.86
Fwd EY9.18%
FCF(TTM)3.91
FCFY41.71%
OCF(TTM)4.77
OCFY50.93%
SpS16.25
BVpS12.91
TBVpS-4.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.18%
ROE -3.22%
ROCE 1.34%
ROIC 0.81%
ROICexc 1.06%
ROICexgc 3.87%
OM 2.46%
PM (TTM) N/A
GM 90.35%
FCFM 24.05%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 4.55
Debt/EBITDA 2.5
Cap/Depr 13.39%
Cap/Sales 5.31%
Interest Coverage 250
Cash Conversion 69.7%
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 2.29
Altman-Z 1.29
F-Score6
WACC5.57%
ROIC/WACC0.15
Cap/Depr(3y)8.81%
Cap/Depr(5y)10.92%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
EPS Next Y253.57%
EPS Next 2Y102.74%
EPS Next 3Y64.12%
EPS Next 5Y34.56%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%
Revenue Next Year10.63%
Revenue Next 2Y7.23%
Revenue Next 3Y5.57%
Revenue Next 5Y5.18%
EBIT growth 1Y116.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1517.96%
EBIT Next 3Y175.9%
EBIT Next 5Y88.12%
FCF growth 1Y27.27%
FCF growth 3Y16.28%
FCF growth 5Y14.31%
OCF growth 1Y37.41%
OCF growth 3Y12.65%
OCF growth 5Y10.94%